COVID-19 & Cancer: Clinical Trials During COVID-19 - Metastatic Breast Cancer Trial Talk


Despite COVID-19’s impact on medical care, researchers are working hard to keep clinical trials open, recruiting, and on time. It’s clear that the effects of the pandemic on cancer clinical trials have the opportunity to outlast COVID itself. The FDA has established guidelines and policies to help trial teams maintain ongoing trials and recruit for new ones. Below you will find information about the impact of coronavirus on cancer clinical trials, ideas on what clinical trials could look like post-pandemic, guidelines from the FDA, and ways you can participate in trials from home.

If you are on a clinical trial or considering a clinical trial, talk to your doctor or the clinical trial team to learn how your hospital and your trial may be affected. 

Impact of COVID-19 on Cancer Clinical Trials 

Future of Clinical Trials

FDA Guidance on Clinical Trials

Trials from Home

For all COVID-19 related information, visit the COVID-19 & Cancer main page.

To find clinical trials, check out the New Metastatic Breast Cancer Trials page.

Last Modified on March 31, 2021



for past articles or specific information.